Jubilant Cadista Pharmaceuticals, a generic prescription pharmaceuticals company, broke ground on an expansion of the company’s U.S. headquarters in Salisbury, Maryland last week.
The expansion, which will be completed in fourth quarter of 2014, will double the company’s facility and include additional space for production, packing, warehouse and distribution, enabling it to double the number of products it produces.
“The site expansion will allow us to grow and accommodate our plans of doubling the number of products over the next two years,” Scott Delaney, CEO of Jubilant Cadista.
The company, whose parent is India-based parent Jubilant Life Sciences, has expanded over the past eight years growing from 30 employees to 300 in 2013. Over the next five years the company plans to add as many as 200 employees.
“It is a testament to our outstanding workforce and supportive climate for life sciences companies that a world-class company like Cadista Pharmaceuticals has chosen to expand and add jobs on our Eastern Shore,” said Governor Martin O’Malley.
“Our trade mission to India – the first by a sitting Maryland Governor – was a tremendous success. We brought home more than $60 million in business deals for Maryland companies and we are continuing to see companies, like Cadista, invest in Maryland,” O’Malley added.
